Submit a Study

InvestigatorsAn investigator requesting review of a new study for a protocol that has never been reviewed by Schulman must submit:

Note: If submitting a Canadian study, please refer to our Research in Canada page.

  • Single Site Study Submission Form or Minimal Risk Single Site Submission Form
  • Protocol
  • Template Informed Consent Document(s) (Microsoft Word format required unless utilizing electronic informed consent [eIC])
  • Curriculum Vitae (CV) of Principal Investigator/Qualified Investigator (PI/QI) and each *Sub-Investigator (Sub-I), if not already on file – CVs must reflect experience, be signed and dated within the past 2 years.
    • * Sub-I CVs are not generally required for site submissions on studies that have been qualified by the Board as minimal risk and/or non-interventional.

And, if applicable:


Schulman IRB has IRB meetings every day of the business week, with special submission deadlines for Phase I and Canadian-based research.

Full Board Review Submission Deadlines

Submission deadline is one week prior to intended meeting.

Assignment to a Board meeting is dependent upon the complete and accurate submission of all required documents. Refer to Federally Funded/FWA Study, Submitting a Device Study and Transfer of IRB Oversight for Study for additional requirements for these types of study submissions.

Please note: Full Board review of studies with Canadian sites are reviewed only at Friday Board meetings.